Clinical neuropathy (center) | Enrolled | Neural leprosy | % | Subclinical neuropathy | Enrolled | Neural leprosy | % |
---|---|---|---|---|---|---|---|
A | 82 | 9 | 11.0 | 68 | 11 | 16.2 | |
B | 230 | 34 | 14.8 | 138 | 17 | 12.3 | |
C | 232 | 6 | 2.6 | 118 | 0 | - | |
D | 166 | 24 | 14.5 | 48 | 0 | - | |
E | 101 | 1 | 1.0 | NA | - | - | |
F | 57 | 2 | 3.5 | NA | - | - | |
Total | 868 | 76 | 8.8 | 372 | 28 | 7.5 |
Clinical neuropathy | N | Age | Subclinical neuropathy | N | Age |
---|---|---|---|---|---|
Men | 66 | 32.1 (16–60) | 26 | 31.7 (16–60) | |
Women | 10 | 37.5 (17–45) | 2 | 37.5 (35–40) |
Subclinical trial | Greater auricular | Ulnar | Median | Radial cutaneous | Lateral popliteal | Posterior tibial | Sural |
---|---|---|---|---|---|---|---|
N = 28 (56 Nerves) | 9 | 29 | 7 | 17 | 17 | 6 | 19 |
% | 16.1 | 51.8 | 12.5 | 30.4 | 30.4 | 10.7 | 33.9 |
Clinical trial | Greater auricular | Ulnar | Median | Radial cutaneous | Lateral popliteal | Posterior tibial | Sural |
---|---|---|---|---|---|---|---|
N = 76 (152 Nerves) | 10 | 78 | 24 | 36 | 40 | 27 | 21 |
% | 6.6 | 51.3 | 15.8 | 23.7 | 26.3 | 17.8 | 13.8 |
N = 76 152 nerves | Facial | Ulnar | Median | Radial cutaneous | Lateral popliteal | Posterior tibial | Sural |
---|---|---|---|---|---|---|---|
NFI | 0 | 82 | 42 | 48 | 21 | 55 | 55 |
% | 0 | 53.6 | 27.6 | 31.2 | 13.8 | 36.2 | 36.2 |
N = 160 nerves | % | |
---|---|---|
Enlarged and loss | 65 | 40.6 |
Not enlarged no loss | 60 | 37.5 |
Not enlarged but loss | 19 | 11.9 |
Enlarged no loss | 16 | 10.0 |
Ulnar nerve | N | % | Lateral popliteal | N | % |
---|---|---|---|---|---|
Right | 26 | 34.2 | 1 | 1.4 | |
Right and Left | 21 | 27.6 | 8 | 10.5 | |
Left | 14 | 18.4 | 8 | 10.5 | |
No impairment | 15 | 19.7 | 59 | 77.6 |